By regulating cyclinD1, MMP9 and p27, knockdown of S100A7 reduces epithelial ovarian cancer (EOC) cell proliferation, migration and invasion, and enhances chemosensitivity to cisplatin. This evidence concerns the gene MMP9 and ovarian carcinoma.